SV
I
HealthcareDiagnostics & ResearchUnited States

IDXX.US · IDEXX Laboratories, Inc.

NMS · US · USD

Latest price548.22 USD
30D+5.24%
Vs. base value+19.9%

Research summary

IDXX.US latest organized financial period shows revenue grew +10.42% YoY and net income grew +19.33% YoY. Current price is about 548 USD, while the model base case is about 457 USD; the current price sits +19.9% versus the base case. This summary is intended for public-information research and model review.

Key financial trend

Annual financial metrics with switchable views. · Unit: USD

10 records
Revenue4B USD
Net income1B USD
Free cash flow1B USD
Operating cash flow1B USD

Price trend

Price date: 2026/04/28 · Updated: 2026/04/29 07:22

Valuation model range

Hover each model row to inspect formulas and inputs.

Current price548.22 USD
Base value457.20 USD
Vs. base+19.9%
Price date2026/04/28
282.60 USD457.20 USD595.74 USD

+19.91%

Calculated

DCF

Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.

349.17 USD604.24 USD815.98 USD

-9.27%

604.24 USDCurrent price is close to the base model value.
Calculated

Owner Earnings

Uses recent net income as an owner-earnings proxy and discounts scenario growth.

282.60 USD457.20 USD595.74 USD

+19.91%

457.20 USDCurrent price is 19.9% above the base model value.
Calculated

Reverse DCF

Solves the forward FCF growth rate implied by the current price.

Implied growth14.7%

Current price implies roughly 14.7% annualized FCF growth.

14.7%Current price implies roughly 14.7% annualized FCF growth.
Calculated

Earnings Power Value

Estimates earnings power value without assuming growth.

129.52 USD129.52 USD129.52 USD

+323%

129.52 USDCurrent price is 323.3% above the base model value.

Updated: 2026/04/29 07:22

Ad placement

Quarterly and annual financial table

Financial DetailsShowing latest 5 / 10
PeriodTypeRevenueNet IncomeFree Cash FlowDiluted EPS
2025/12/30Annual4B USD1B USD1B USD13.08
2024/12/30Annual4B USD888M USD808M USD10.67
2023/12/30Annual4B USD845M USD773M USD10.06
2022/12/30Annual3B USD679M USD394M USD8.03
2021/12/30Annual3B USD745M USD636M USD8.6
Ad placement